A Randomized, Open-label Phase III Trial of Mapisal® Versus an Urea Hand-foot Cream as Prophylaxis for Capecitabine-induced Hand-foot Syndrome in Patients With Gastrointestinal Tumors or Breast Cancer

Clinical trial NCT01626781 · NO_LONGER_AVAILABLE

Trial details

NCT number: NCT01626781
Sponsor: AIO-Studien-gGmbH
Status: NO_LONGER_AVAILABLE
Study type: EXPANDED_ACCESS

the Treatment Hand-foot Syndrome Patients With Gastrointestinal Tumors or Breast Cancer, Who Are Treated With Capecitabine

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.